Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Journal
Select Journal
Publication Year
1 year
3 years
5 years
10 years
From
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
To
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Publication Type
Case Reports
Comment
Comparative Study
Editorial
Letter
Journal Article
Review
Preprint
Associated Data
YES
Found 408,190 results
Sort by:
Best match
Best match
Most recent
Publication date
Filters:
Anticancer
QSAR Prediction Model to Search for Compounds with Selective Cytotoxicity Against Oral Cell Cancer.
Junko Nagai, Mai Imamura, Hiroshi Sakagami, Yoshihiro Uesawa
Medicines (Basel)
. Apr 01, 2019.6(2): Electronic
Source:PubMed
PMID:
30939759
doi:10.3390/medicines6020045
Anticancer Activity of Artemisinin and its Derivatives.
Silvia Slezakova, Jana Ruda-Kucerova
Anticancer Res
. 11, 2017.37(11):5995-6003 Print
Source:PubMed
PMID:
29061778
doi:10.21873/anticanres.12046
[The pace of development of approved anticancer agents in Japan].
T Himori, M Yokoyama, A Wakui, T Saito
Gan To Kagaku Ryoho
. Oct, 1985.12(10):1899-904 Print
Source:PubMed
PMID:
4051508
doi:
Promising anticancer activities and mechanisms of action of active compounds from the medicinal herb Centipeda minima (L.) A. Braun & Asch.
Yong-Qiang Liu, Guang-Biao Zhou
Phytomedicine
. Nov, 2022.106:154397 Print-Electronic
Source:PubMed
PMID:
36084403
doi:10.1016/j.phymed.2022.154397
Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment.
Jinhua Li, Ting Zhang, Qiong Shi, Gang Lv, Xiaohu Zhou, Namrta Choudhry, Julia Kalashova, Chenglu Yang, Hongmei Li, Yan Long, Balasubramaniyan Sakthivel, Naganna Nimishetti, Hong Liu, Thaddeus D Allen, Jing Zhang, Dun Yang
ACS Pharmacol Transl Sci
. Aug 11, 2023.6(8):1155-1163 Electronic-eCollection
Source:PubMed
PMID:
37588758
doi:10.1021/acsptsci.3c00054
Subcutaneous Trastuzumab Combined with Pertuzumab and Docetaxel as First-line Treatment of Advanced HER2-positive Breast Cancer.
Dimitra Stefanou, Stefania Kokkali, Elli-Sophia Tripodaki, Maria Drizou, Elpida Magou, Dimosthenis Zylis, Maria Prevezanou, Matthaios Kapiris, Despoina Nasi, Anna Ntokou, Mary Dede, Alexandros Ardavanis
Anticancer Res
. Nov, 2018.38(11):6565-6569 Print-Electronic
Source:PubMed
PMID:
30396987
doi:10.21873/anticanres.13023
Association of Basal and Calcium-stimulated Calcitonin Levels with Pathological Findings After Total Thyroidectomy.
Georgios Papadakis, Ioannis Keramidas, Eleni Triantafillou, Fotini Kanouta, Theodora Pappa, Victoria Kaltzidou, Athanasia Tertipi, Lydia Iordanidou, Erasmia Trivizaki, Gino Vecchini, Vassiliki Villiotou, Anastasios Pappas
Anticancer Res
. Jul, 2015.35(7):4251-8 Print
Source:PubMed
PMID:
26124386
doi:
Design and Development of Triazole Derivatives as Prospective Anticancer Agents: A Review.
Harshita Sachdeva, Mohammad Saquib, Kumud Tanwar
Anticancer Agents Med Chem
. 2022.22(19):3269-3279 Print
Source:PubMed
PMID:
35418291
doi:10.2174/1871520622666220412133112
Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.
Emmanuel Yohana, Appolinary Kamuhabwa, Phares Mujinja
East Afr J Public Health
. Mar, 2011.8(1):52-7 Print
Source:PubMed
PMID:
22066285
doi:
The inhibition of constitutive androstane receptor-mediated pathway enhances the effects of anticancer agents in ovarian cancer cells.
Yan Wang, Hisashi Masuyama, Etsuko Nobumoto, Guangmei Zhang, Yuji Hiramatsu
Biochem Pharmacol
. Aug 15, 2014.90(4):356-66 Print-Electronic
Source:PubMed
PMID:
24928535
doi:10.1016/j.bcp.2014.06.003
0
Previous
Next